Analyst Estimates: Here's What Brokers Think Of Davide Campari-Milano N.V. (BIT:CPR) After Its Interim Report

Last week saw the newest half-year earnings release from Davide Campari-Milano N.V. (BIT:CPR), an important milestone in the company's journey to build a stronger business. It was a credible result overall, with revenues of €1.5b and statutory earnings per share of €0.17 both in line with analyst estimates, showing that Davide Campari-Milano is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Following last week's earnings report, Davide Campari-Milano's 19 analysts are forecasting 2025 revenues to be €3.11b, approximately in line with the last 12 months. Per-share earnings are expected to shoot up 91% to €0.30. In the lead-up to this report, the analysts had been modelling revenues of €3.10b and earnings per share (EPS) of €0.29 in 2025. So the consensus seems to have become somewhat more optimistic on Davide Campari-Milano's earnings potential following these results.

View our latest analysis for Davide Campari-Milano

There's been no major changes to the consensus price target of €6.73, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Davide Campari-Milano, with the most bullish analyst valuing it at €10.00 and the most bearish at €4.20 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Davide Campari-Milano's revenue growth is expected to slow, with the forecast 2.2% annualised growth rate until the end of 2025 being well below the historical 12% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 4.3% per year. Factoring in the forecast slowdown in growth, it seems obvious that Davide Campari-Milano is also expected to grow slower than other industry participants.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Davide Campari-Milano following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Davide Campari-Milano's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Davide Campari-Milano going out to 2027, and you can see them free on our platform here..

Plus, you should also learn about the 3 warning signs we've spotted with Davide Campari-Milano .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.